Analyst Ratings for Sorrento Therapeutics (SRNE)

SRNE Rating Summary

  |   Expand Research on SRNE
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 9 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/13/2023 Dawson James Jason Kolbert Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.94
(0.00)		 -100% Details
11/2/2022 Cantor Fitzgerald Brandon Folkes New Coverage Overweight
(N/A)		 5.00
(N/A)		 1.58
(0.00)		 -100% Details